7Baggers

Fulgent Genetics, Inc
(NASDAQ:FLGT) 

FLGT stock logo

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagn...

Founded: 2011
Full Time Employees: 473
CEO / Co-Founder: Ming Hsieh 
Sector: Healthcare
Industry: Diagnostics & Research
HealthcareGeneticsGenomics
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                           
      revenue
    		71,138,000 83,336,000 84,069,000 81,803,000 73,463,000 76,214,000 71,743,000 71,028,000 64,485,000 70,505,000 84,687,000 67,853,000 66,168,000 67,704,000 105,655,000 125,341,000 320,268,000 251,671,000 227,868,000 153,616,000 359,429,000 294,978,000 101,716,000 17,265,000 7,753,000 8,387,000 10,347,000 8,424,000 5,370,000 5,673,000 5,625,000 5,400,000 4,653,000 4,281,000 4,503,000 4,640,000 5,306,000 5,854,000 5,011,000 
      yoy
    		-3.16% 9.34% 17.18% 15.17% 13.92% 8.10% -15.28% 4.68% -2.54% 4.14% -19.85% -45.87% -79.34% -73.10% -53.63% -18.41% -10.90% -14.68% 124.02% 789.75% 4536.00% 3417.09% 883.05% 104.95% 44.38% 47.84% 83.95% 56.00% 15.41% 32.52% 24.92% 16.38% -12.31% -26.87% -10.14%     
      qoq
    		-14.64% -0.87% 2.77% 11.35% -3.61% 6.23% 1.01% 10.15% -8.54% -16.75% 24.81% 2.55% -2.27% -35.92% -15.71% -60.86% 27.26% 10.45% 48.34% -57.26% 21.85% 190.00% 489.15% 122.69% -7.56% -18.94% 22.83% 56.87% -5.34% 0.85% 4.17% 16.05% 8.69% -4.93% -2.95% -12.55% -9.36% 16.82%  
      cost of revenue
    		49,648,000 50,754,000 48,557,000 47,368,000 45,117,000 44,365,000 44,972,000 44,537,000 42,381,000 45,276,000 44,843,000 47,281,000 47,357,000 54,717,000 59,560,000 60,065,000 77,725,000 62,134,000 43,466,000 35,858,000 74,075,000 51,772,000 26,261,000 7,717,000 4,057,000 3,634,000 3,885,000 3,620,000 2,968,000 2,769,000 2,612,000 2,544,000 2,772,000 2,545,000 2,268,000 1,879,000 1,859,000 1,864,000 2,143,000 
      gross profit
    		21,490,000 32,582,000 35,512,000 34,435,000 28,346,000 31,849,000 26,771,000 26,491,000 22,104,000 25,229,000 39,844,000 20,572,000 18,811,000 12,987,000 46,095,000 65,276,000 242,543,000 189,537,000 184,402,000 117,758,000 285,354,000 243,206,000 75,455,000 9,548,000 3,696,000 4,753,000 6,462,000 4,804,000 2,402,000 2,904,000 3,013,000 2,856,000 1,881,000 1,736,000 2,235,000 2,761,000 3,447,000 3,990,000 2,868,000 
      yoy
    		-24.19% 2.30% 32.65% 29.99% 28.24% 26.24% -32.81% 28.77% 17.51% 94.26% -13.56% -68.48% -92.24% -93.15% -75.00% -44.57% -15.00% -22.07% 144.39% 1133.33% 7620.62% 5016.89% 1067.67% 98.75% 53.87% 63.67% 114.47% 68.21% 27.70% 67.28% 34.81% 3.44% -45.43% -56.49% -22.07%     
      qoq
    		-34.04% -8.25% 3.13% 21.48% -11.00% 18.97% 1.06% 19.85% -12.39% -36.68% 93.68% 9.36% 44.84% -71.83% -29.38% -73.09% 27.97% 2.78% 56.59% -58.73% 17.33% 222.32% 690.27% 158.33% -22.24% -26.45% 34.51% 100.00% -17.29% -3.62% 5.50% 51.83% 8.35% -22.33% -19.05% -19.90% -13.61% 39.12%  
      gross margin %
    		30.21% 39.10% 42.24% 42.10% 38.59% 41.79% 37.32% 37.30% 34.28% 35.78% 47.05% 30.32% 28.43% 19.18% 43.63% 52.08% 75.73% 75.31% 80.92% 76.66% 79.39% 82.45% 74.18% 55.30% 47.67% 56.67% 62.45% 57.03% 44.73% 51.19% 53.56% 52.89% 40.43% 40.55% 49.63% 59.50% 64.96% 68.16% 57.23% 
      operating expenses
    		                                       
      research and development
    		14,176,000 14,170,000 13,860,000 13,480,000 12,395,000 12,113,000 11,783,000 13,486,000 11,434,000 11,952,000 10,014,000 9,692,000 9,782,000 8,509,000 7,507,000 6,905,000 5,989,000 7,464,000 6,021,000 5,312,000 5,422,000 4,576,000 3,177,000 1,849,000 1,978,000 1,795,000 1,744,000 1,574,000 1,424,000 1,426,000 1,438,000 1,212,000 1,458,000 1,324,000 1,128,000 920,000 851,000 819,000 1,523,000 
      selling and marketing
    		12,221,000 10,978,000 11,642,000 12,286,000 8,465,000 9,538,000 9,124,000 8,595,000 8,989,000 10,500,000 10,161,000 10,723,000 10,083,000 10,253,000 9,859,000 10,866,000 7,940,000 8,200,000 6,012,000 5,219,000 5,008,000 5,081,000 5,014,000 3,260,000 1,597,000 1,635,000 1,687,000 1,304,000 1,272,000 1,128,000 1,115,000 1,279,000 1,130,000 1,080,000 1,383,000 851,000 891,000 798,000 893,000 
      general and administrative
    		27,684,000 41,646,000 23,335,000 26,392,000 25,291,000 24,341,000 20,950,000 21,326,000 21,489,000 31,706,000 17,498,000 17,993,000 21,802,000 28,793,000 26,266,000 30,240,000 25,775,000 22,102,000 12,299,000 8,329,000 8,002,000 7,640,000 3,741,000 1,799,000 2,035,000 1,732,000 1,522,000 1,631,000 1,529,000 1,379,000 1,306,000 1,366,000 1,487,000 1,402,000 1,205,000 1,140,000 1,486,000 1,115,000 1,147,000 
      amortization of intangible assets
    		2,031,000 2,026,000 2,025,000 1,990,000 1,990,000 1,992,000 1,993,000 1,990,000 1,990,000 1,958,000 1,957,000 1,962,000 1,968,000 2,010,000 2,006,000 1,575,000 906,000                       
      total operating expenses
    		56,112,000 68,820,000 50,862,000 54,148,000 48,141,000 47,984,000 43,850,000 45,397,000 43,902,000 176,350,000 39,630,000 40,370,000 43,635,000 49,539,000 45,743,000 52,482,000 40,610,000 38,677,000 25,129,000 18,860,000 18,432,000 17,297,000 11,932,000 6,908,000 5,610,000 5,162,000 4,953,000 4,509,000 4,225,000 3,933,000 3,859,000 3,857,000 4,075,000 3,806,000 3,716,000 2,911,000 3,228,000 2,732,000 3,563,000 
      operating income
    		-34,622,000 -36,238,000 -15,350,000 -19,713,000 -19,795,000 -16,135,000 -17,079,000 -18,906,000 -21,798,000 -151,121,000 214,000 -19,798,000 -24,824,000 -36,552,000 352,000 12,794,000 201,933,000 150,860,000 159,273,000 98,898,000 266,922,000 225,909,000 63,523,000 2,640,000 -1,914,000 -409,000 1,509,000 295,000 -1,823,000 -1,029,000 -846,000 -1,001,000 -2,194,000 -2,070,000 -1,481,000 -150,000 219,000 1,258,000 -695,000 
      yoy
    		74.90% 124.59% -10.12% 4.27% -9.19% -89.32% -8080.84% -4.51% -12.19% 313.44% -39.20% -254.74% -112.29% -124.23% -99.78% -87.06% -24.35% -33.22% 150.73% 3646.14% -14045.77% -55334.47% 4109.61% 794.92% 4.99% -60.25% -278.37% -129.47% -16.91% -50.29% -42.88% 567.33% -1101.83% -264.55% 113.09%     
      qoq
    		-4.46% 136.08% -22.13% -0.41% 22.68% -5.53% -9.66% -13.27% -85.58% -70717.29% -101.08% -20.25% -32.09% -10484.09% -97.25% -93.66% 33.85% -5.28% 61.05% -62.95% 18.15% 255.63% 2306.17% -237.93% 367.97% -127.10% 411.53% -116.18% 77.16% 21.63% -15.48% -54.38% 5.99% 39.77% 887.33% -168.49% -82.59% -281.01%  
      operating margin %
    		-48.67% -43.48% -18.26% -24.10% -26.95% -21.17% -23.81% -26.62% -33.80% -214.34% 0.25% -29.18% -37.52% -53.99% 0.33% 10.21% 63.05% 59.94% 69.90% 64.38% 74.26% 76.59% 62.45% 15.29% -24.69% -4.88% 14.58% 3.50% -33.95% -18.14% -15.04% -18.54% -47.15% -48.35% -32.89% -3.23% 4.13% 21.49% -13.87% 
      other income
    		10,000 44,000 -5,000 46,000 68,000 7,000 544,000                                 
      interest income
    		8,651,000 6,936,000 7,874,000 8,091,000 8,018,000 8,123,000 8,090,000                                 
      interest expense
    		-17,000 -16,000 -28,000 -17,000 -14,000 -40,000 -14,000                                 
      total other income
    		8,644,000 6,964,000 7,841,000 -1,806,000 8,072,000 8,090,000 -1,453,000                                 
      income before income taxes
    		-25,978,000 -29,274,000 -7,509,000 -21,519,000 -11,723,000 -8,045,000 -18,532,000 -11,214,000 -14,173,000 -7,222,250 6,860,000 -14,700,000 -21,049,000    201,978,000                    338,000 1,316,000 -690,000 
      provision for income taxes
    		-704,000    176,000 -1,855,000 -3,838,000   -10,862,000 20,326,000 -3,110,000    2,653,000 48,421,000 47,148,000 37,545,000 23,589,000 66,513,000 58,571,000 14,526,000 -599,000 34,000 20,250 61,000 7,000 13,000   -100,000 -434,000 -596,000 -415,000 -110,000  503,000 417,000 
      net loss from consolidated operations
    		-25,274,000 -23,650,000 -6,826,000 -19,256,000 -11,899,000 -9,407,500 -14,694,000 -9,090,000 -13,846,000                               
      net loss attributable to noncontrolling interests
    		448,000 232,000 218,000 299,000 369,000 302,000 46,000 380,000 384,000 6,185,000 359,000 361,000    438,000 422,000 662,000 298,000 165,000                    
      net loss attributable to fulgent
    		-24,826,000 -23,418,000 -6,608,000 -18,957,000 -11,530,000 -9,205,000 -14,648,000 -8,710,000 -13,462,000                               
      net loss per common share attributable to fulgent
    		                                       
      basic
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      diluted
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      weighted-average common shares:
    		                                       
      basic
    		30,881,000 30,777,000 30,749,000 30,544,000 30,832,000 30,235,000 30,416,000 30,098,000 29,769,000 29,784,000 30,013,000 29,813,000 29,536,000 30,097,000 30,174,000 30,362,000 30,234,000 29,408,000 29,673,000 29,150,000 28,831,000 22,694,000 22,062,000 21,747,000 21,566,000 18,709,000 18,501,000 18,343,000 18,228,000  18,012,000 17,919,000 17,864,000  17,752,000 17,711,000 17,676,000   
      diluted
    		30,881,000 30,777,000 30,749,000 30,544,000 30,832,000 30,235,000 30,416,000 30,098,000 29,769,000 29,784,000 30,013,000 29,813,000 29,536,000 30,964,000 30,867,000 31,189,000 31,240,000 30,976,000 31,170,000 30,830,000 30,770,000 24,056,000 23,539,000 22,920,000 21,566,000 18,709,000 19,456,000 19,021,000 18,228,000  18,012,000 17,919,000 17,864,000  17,752,000 17,711,000 18,178,000   
      impairment loss
    		   -9,926,000                                    
      benefit from income taxes
    		 -692,500 -683,000 -2,263,000    -2,124,000 -327,000     -9,386,000 414,000               -213,000 -318,000      106,000   
      operating expenses:
    		                                       
      impairment of available-for-sale debt securities
    		      -10,073,000                                 
      interest and other income
    		       7,692,000 7,625,000 5,925,000 6,646,000 5,098,000 3,775,000 3,090,000 1,405,000 958,000 45,000 -35,000 496,000 604,000 282,000 589,000 421,000 275,000 241,000 249,000 189,000 192,000 207,000 98,000 143,000 98,000 95,000 97,000 145,000 120,000 119,000 58,000 5,000 
      net loss per common share attributable to fulgent:
    		                                       
      basic
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      diluted
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      restructuring costs
    		             -26,000 105,000 2,896,000                        
      net income from consolidated operations
    		         -134,334,000 -13,466,000 -11,590,000 -15,849,000 -24,076,000 1,343,000 11,099,000 153,557,000 103,677,000 122,224,000 79,647,000                    
      net income attributable to fulgent
    		         -128,149,000 -13,107,000 -11,229,000 -15,340,000 -23,832,000 1,719,000 11,537,000 153,979,000 104,339,000 122,522,000 79,812,000                    
      net income per common share attributable to fulgent:
    		                                       
      basic
    		         -4,300 -440 -380 -520 -770 60 380 5,090 3,460 4,130 2,740 6,960 7,240 2,110 150  -10 80 20    -60 -110       
      diluted
    		         -4,300 -440 -380 -520 -750 60 370 4,930 3,340 3,930 2,590 6,520 6,840 1,980 140  -10 80 20    -60 -110       
      (benefit from) benefit from income taxes
    		            -5,200,000                           
      net income attributable to noncontrolling interests
    		            509,000 244,000 376,000                         
      income before income taxes and gain on equity method investment
    		             54,371,750 1,757,000 13,752,000                        
      income before gain on equity method investment
    		             41,499,750 1,343,000 11,099,000                        
      gain on equity method investment
    		                   3,734,000                    
      amortization of acquisition-related intangible assets
    		                 199,250 797,000                     
      income before income taxes, gain on equity method investments and equity loss in investee
    		                 131,618,750 159,769,000                     
      income before gain on equity method investments and equity loss in investee
    		                 99,707,000 122,224,000                     
      gain on equity-method investments
    		                                       
      equity loss in investee
    		                     143,000 -189,000 -193,000 -249,000 -174,000 -175,000 -149,000 -279,000 -234,000 -210,000 -246,000 -245,000 -247,000 -172,000     
      income before income taxes, gain on equity method investment and equity loss in investee
    		                   99,502,000                    
      income before gain on equity method investment and equity loss in investee
    		                   75,913,000                    
      income before income taxes and equity loss in investee
    		                    267,204,000   2,915,000  -160,000 1,698,000 487,000    -903,000 -2,099,000 -1,973,000 -1,336,000     
      income before equity loss in investee
    		                    200,691,000   3,514,000  -122,000 1,637,000 480,000    -803,000 -1,665,000 -1,377,000 -921,000     
      net income
    		                    200,691,000 166,307,000 46,638,000 3,321,000 -1,956,000 -296,000 1,462,000 331,000 -1,908,000 -2,053,000 -595,000 -1,049,000 -1,910,000 -1,624,000 -1,093,000 -25,000 232,000 813,000 -1,107,000 
      yoy
    		                    -10360.28% -56284.80% 3090.01% 903.32% 2.52% -85.58% -345.71% -131.55% -0.10% 26.42% -45.56% 4096.00% -923.28% -299.75% -1.26%     
      qoq
    		                    20.68% 256.59% 1304.34% -269.79% 560.81% -120.25% 341.69% -117.35% -7.06% 245.04% -43.28% -45.08% 17.61% 48.58% 4272.00% -110.78% -71.46% -173.44%  
      net income margin %
    		0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 55.84% 56.38% 45.85% 19.24% -25.23% -3.53% 14.13% 3.93% -35.53% -36.19% -10.58% -19.43% -41.05% -37.94% -24.27% -0.54% 4.37% 13.89% -22.09% 
      net income per common share:
    		                                       
      basic
    		         -4,300 -440 -380 -520 -770 60 380 5,090 3,460 4,130 2,740 6,960 7,240 2,110 150  -10 80 20    -60 -110       
      diluted
    		         -4,300 -440 -380 -520 -750 60 370 4,930 3,340 3,930 2,590 6,520 6,840 1,980 140  -10 80 20    -60 -110       
      income before income taxes, equity loss in investee and impairment loss
    		                     226,498,000 63,944,000                 
      income before equity loss in investee and impairment loss
    		                     167,927,000 49,418,000                 
      impairment loss in equity-method investment
    		                     -647,750 -2,591,000                 
      loss before income taxes and equity loss in investee
    		                        -1,673,000    -1,616,000 -931,000 -703,000         
      loss before equity loss in investee
    		                        -1,707,000    -1,629,000 -1,819,000 -385,000         
      net loss per common share:
    		                                       
      basic
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      diluted
    		-800 -760 -210 -620 -370 -305 -480 -290 -450                -90    -100 -50 -30         
      income from continuing operations
    		                                 -1,624,000 -1,093,000 -25,000 232,000 813,000 -1,107,000 
      income from discontinued operations
    		                                       
      continuing operations:
    		                                       
      income per common share:
    		                                       
      basic
    		                                 -12.5 -60  10   
      diluted
    		                                 -12.5 -60  10   
      income before income taxes and equity in net loss of affiliate
    		                                   -30,000    
      income before equity in net loss of affiliate
    		                                   80,000    
      equity in net loss of affiliate
    		                                   -105,000    
      basic and diluted income per common share:
    		                                       
      continuing operations—common stock
    		                                     170 -440 
      weighted-average common shares—outstanding—basic and diluted
    		                                     13,710,000 12,846,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
                                             
        assets
      		                                       
        current assets
      		                                       
        cash and cash equivalents
      		23,399,000 50,193,000 117,641,000 87,880,000 67,281,000 55,144,000 58,042,000 65,111,000 54,677,000 97,473,000 84,076,000 58,348,000 66,172,000 79,506,000 168,770,000 138,780,000 353,069,000 164,894,000 214,877,000 100,461,000 151,461,000 87,426,000 53,031,000 2,431,000 9,302,000 11,965,000 20,522,000 9,165,000 5,288,000 6,736,000 8,489,000 3,654,000 5,274,000 6,490,000 9,478,000 11,473,000 6,734,000 7,897,000  
        marketable securities
      		252,903,000 285,884,000 258,162,000 205,047,000 253,040,000 202,962,000 155,027,000 246,595,000 251,018,000 326,681,000 383,726,000 400,083,000 438,313,000 446,729,000 402,290,000 376,622,000 232,045,000 285,605,000 255,102,000 283,328,000 258,317,000 211,941,000 21,904,000 18,530,000 18,028,000 16,304,000 11,596,000 17,820,000 24,139,000 24,298,000 24,114,000 26,949,000 23,211,000 19,994,000 16,570,000 17,400,000 20,633,000 12,971,000  
        trade accounts receivable, net of allowance for credit losses of 21,420 as of march 31, 2026, and 21,411 as of december 31, 2025
      		69,277,000                                       
        prepaid income taxes
      		109,165,000 107,099,000                                      
        other current assets
      		24,298,000 22,552,000 60,384,000 58,610,000 24,985,000 26,444,000 56,155,000 30,825,000 28,754,000 32,559,000 32,776,000 35,049,000 32,689,000 48,889,000 21,395,000 26,480,000 19,958,000 22,549,000 32,035,000 34,321,000 32,853,000 40,392,000 30,000,000 6,359,000 3,324,000 2,255,000 1,795,000 2,267,000 2,311,000 2,561,000 2,370,000 2,537,000 2,621,000 2,438,000 2,396,000 1,668,000 1,202,000 906,000 4,883,000 
        total current assets
      		479,042,000 550,490,000 507,374,000 428,727,000 416,784,000 353,571,000 326,539,000 399,104,000 386,509,000 507,845,000 549,855,000 528,289,000 580,723,000 627,873,000 696,614,000 675,185,000 765,333,000 611,960,000 622,836,000 566,686,000 659,140,000 523,616,000 195,615,000 41,183,000 37,025,000 37,079,000 39,205,000 34,795,000 36,301,000 39,543,000 41,050,000 38,195,000 36,075,000 32,927,000 32,038,000 34,727,000 33,170,000 26,138,000 17,494,000 
        marketable securities, long-term
      		328,287,000 369,269,000 411,778,000 484,471,000 494,111,000 570,351,000 602,232,000 526,163,000 540,495,000 423,571,000 383,659,000 388,383,000 366,833,000 326,648,000 346,946,000 415,621,000 493,182,000 485,047,000 407,284,000 393,250,000 287,626,000 132,502,000 29,035,000 45,403,000 43,294,000 41,947,000 11,487,000 11,697,000 8,983,000           
        fixed assets
      		116,344,000 112,549,000 111,865,000 110,223,000 107,077,000 105,549,000 106,810,000 93,368,000 86,723,000 83,464,000 85,265,000 87,556,000 79,083,000 81,353,000 81,807,000 86,049,000 68,622,000 62,287,000 60,166,000 51,086,000 46,987,000 40,199,000 17,385,000 6,013,000 5,698,000 5,974,000 6,396,000 5,937,000 6,046,000 6,446,000 6,853,000 7,325,000 6,853,000 7,272,000 6,490,000 6,737,000 5,894,000 6,234,000 5,178,000 
        in-process research & development
      		68,490,000 68,490,000                                      
        other intangible assets
      		85,499,000 64,791,000                                      
        goodwill
      		53,731,000 25,080,000 25,080,000 22,055,000 22,055,000 22,055,000 22,055,000 22,055,000 22,055,000 22,055,000 141,844,000 141,970,000 143,120,000 143,027,000 120,313,000 121,354,000 50,999,000 50,897,000 48,749,000 23,107,000                    
        other long-term assets
      		24,976,000 22,856,000 23,211,000 23,302,000 32,708,000 33,460,000 39,012,000 32,138,000 32,676,000 34,902,000 38,128,000 49,064,000 45,327,000 44,124,000 61,016,000 61,777,000 34,808,000 10,650,000 8,949,000 8,897,000 5,330,000 3,316,000 975,000 80,000 160,000 251,000 409,000 167,000 231,000 17,000 18,000 20,000 30,000 39,000 71,000 61,000 69,000 17,000  
        total assets
      		1,156,369,000 1,213,525,000 1,214,563,000 1,199,838,000 1,205,744,000 1,219,964,000 1,233,763,000 1,232,239,000 1,229,885,000 1,235,328,000 1,358,398,000 1,354,577,000 1,376,767,000 1,386,053,000 1,405,782,000 1,461,662,000 1,465,590,000 1,278,720,000 1,204,668,000 1,049,855,000 999,083,000 700,461,000 247,311,000 95,915,000 89,325,000 88,756,000 61,145,000 56,436,000 55,652,000 53,904,000 54,846,000 55,548,000 55,440,000 57,184,000 58,670,000 58,805,000 58,820,000 58,040,000 22,758,000 
        liabilities and stockholders’ equity
      		                                       
        current liabilities
      		                                       
        accounts payable
      		21,125,000 18,654,000 18,088,000 18,887,000 18,238,000 18,364,000 19,805,000 19,873,000 19,616,000 15,360,000 15,772,000 20,607,000 22,080,000 23,093,000 14,481,000 37,109,000 23,699,000 20,494,000 24,868,000 14,743,000 17,440,000 26,488,000 18,674,000 3,636,000 2,855,000 1,581,000 2,150,000 1,175,000 1,456,000 1,313,000 1,024,000 1,794,000 1,347,000 2,089,000 2,370,000 1,820,000 2,306,000 2,756,000 3,286,000 
        accrued liabilities
      		34,901,000 34,057,000 23,010,000 21,699,000 16,689,000 24,279,000 23,862,000 26,425,000 25,918,000 30,737,000 21,031,000 22,229,000 21,088,000 24,981,000 25,101,000 27,100,000 11,847,000 17,689,000    8,446,000 5,467,000 1,750,000 2,024,000 1,333,000 1,634,000 1,333,000 1,354,000 1,425,000 1,231,000 1,184,000 1,062,000 911,000 781,000 902,000 745,000 436,000 471,000 
        customer deposit
      		30,619,000 28,145,000 28,543,000 27,600,000 27,695,000 27,610,000 26,945,000 26,297,000 27,240,000 22,700,000 18,861,000 14,460,000 11,621,000 10,895,000 25,810,000 28,959,000 17,729,000 19,806,000 41,510,000 45,327,000 17,001,000                   
        contract liabilities
      		3,007,000 3,635,000 2,309,000 2,673,000 2,817,000 2,234,000 2,966,000 2,744,000 2,762,000 2,874,000 2,586,000 2,601,000 2,733,000 3,199,000 2,603,000 10,102,000 14,102,000 14,570,000 7,879,000 6,915,000 13,960,000 26,576,000 18,456,000 622,000 444,000 365,000              
        notes payable, current
      		482,000 476,000 476,000 476,000 476,000                                   
        total current liabilities
      		90,134,000 84,967,000 72,426,000 71,335,000 65,915,000 72,899,000 73,990,000 75,751,000 75,949,000 73,018,000 61,421,000 64,819,000 81,939,000 88,107,000 102,522,000 127,527,000 141,714,000 105,310,000 147,158,000 121,524,000 196,530,000 130,115,000 57,736,000 6,509,000 5,810,000 3,723,000 4,253,000 2,909,000 3,203,000 2,738,000 2,255,000 2,978,000 2,409,000 3,000,000 3,151,000 2,827,000 3,281,000 3,316,000 5,010,000 
        deferred tax liabilities
      		6,982,000 6,936,000 7,040,000 6,124,000 6,237,000 6,370,000 6,734,000 6,948,000 7,405,000 7,962,000                              
        unrecognized tax benefits
      		5,727,000 7,283,000 6,783,000 4,838,000 4,700,000 4,563,000 6,326,000 6,295,000 5,978,000 5,978,000 9,555,000 9,836,000 9,836,000 9,836,000 1,826,000 1,730,000 1,210,000 725,000 534,000 505,000 474,000 377,000 389,000                 
        other long-term liabilities
      		9,372,000 7,624,000 7,557,000 5,905,000 6,122,000 6,973,000 11,815,000 14,397,000 13,907,000 15,084,000 15,755,000 16,596,000 16,073,000 18,235,000 20,037,000 21,672,000 9,706,000 6,805,000 6,576,000 1,202,000 513,000 14,000        14,000 11,000 9,000 6,000 6,000 5,000 2,000  2,000  
        total liabilities
      		112,215,000 106,810,000 93,806,000 88,202,000 82,974,000 90,805,000 98,865,000 103,391,000 103,239,000 102,042,000 96,564,000 91,251,000 107,848,000 116,178,000 124,385,000 150,929,000 152,630,000 112,840,000 160,215,000 129,130,000 197,517,000 131,074,000 60,356,000 8,872,000 7,953,000 5,979,000 6,619,000 5,294,000 5,691,000 2,752,000 2,266,000 2,987,000 2,415,000 3,006,000 3,399,000 3,072,000 3,524,000 3,561,000 5,513,000 
        commitments and contingencies
      		                                       
        stockholders’ equity
      		                                       
        common stock, 0.0001 par value per share...
      		4,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 1,000 
        preferred stock, 0.0001 par value per share...
      		                                       
        additional paid-in capital
      		540,141,000 574,520,000 565,690,000 550,599,000 543,903,000 543,126,000 532,909,000 522,420,000 511,329,000 501,718,000 514,262,000 506,075,000 495,981,000 486,585,000 477,814,000 504,066,000 507,046,000 501,908,000 483,731,000 482,255,000 450,855,000 418,065,000 201,772,000 148,056,000 146,948,000 146,058,000 117,478,000 115,532,000 114,790,000 114,203,000 113,600,000 113,011,000 112,431,000 111,884,000 111,299,000 110,746,000 110,301,000 109,734,000 73,211,000 
        accumulated other comprehensive income
      		4,536,000 7,512,000 6,823,000 5,998,000 4,335,000 -368,000 9,178,000 -877,000 -1,102,000 1,205,000        -759,000 -212,000 -265,000 -216,000 438,000 607,000 1,049,000 -193,000 146,000 179,000 203,000 95,000   -82,000 -87,000 -44,000 10,000     
        retained earnings
      		505,128,000 529,954,000 553,372,000 559,980,000 578,937,000 590,467,000 596,355,000 611,003,000 619,713,000 633,175,000 761,324,000 774,431,000 785,660,000 801,000,000 824,832,000 823,113,000 811,576,000 657,597,000 553,258,000 430,736,000 350,924,000 150,881,000                  
        total fulgent stockholders’ equity
      		1,049,809,000 1,111,989,000 1,125,888,000 1,116,580,000 1,127,178,000 1,133,228,000 1,138,445,000 1,132,549,000 1,129,943,000  1,258,698,000 1,259,763,000 1,264,448,000                           
        noncontrolling interest
      		-5,655,000 -5,274,000 -5,131,000 -4,944,000 -4,408,000 -4,069,000 -3,547,000 -3,701,000 -3,297,000 -2,815,000 3,136,000 3,563,000 4,471,000 3,190,000 4,350,000 5,968,000 6,828,000 7,131,000 7,673,000 7,996,000                    
        total stockholders’ equity
      		1,044,154,000 1,106,715,000 1,120,757,000 1,111,636,000 1,122,770,000 1,129,159,000 1,134,898,000 1,128,848,000 1,126,646,000 1,133,286,000 1,261,834,000 1,263,326,000 1,268,919,000 1,269,875,000 1,281,397,000 1,310,733,000 1,312,960,000 1,165,880,000 1,044,453,000 920,725,000 801,566,000 569,387,000 186,955,000 87,043,000 81,372,000 82,777,000 54,526,000 51,142,000 49,961,000 51,152,000 52,580,000 52,561,000 53,025,000 54,178,000 55,271,000 55,733,000 55,296,000   
        total liabilities and stockholders’ equity
      		1,156,369,000 1,213,525,000 1,214,563,000 1,199,838,000 1,205,744,000 1,219,964,000 1,233,763,000 1,232,239,000 1,229,885,000 1,235,328,000 1,358,398,000 1,354,577,000 1,376,767,000 1,386,053,000 1,405,782,000 1,461,662,000 1,465,590,000 1,278,720,000 1,204,668,000 1,049,855,000 999,083,000 700,461,000 247,311,000 95,915,000 89,325,000 88,756,000 61,145,000 56,436,000 55,652,000 53,904,000 54,846,000 55,548,000 55,440,000 57,184,000 58,670,000 58,805,000 58,820,000   
        trade accounts receivable, net of allowance for credit losses of 21,411 as of december 31, 2025, and 20,458 as of december 31, 2024
      		 84,762,000                                      
        trade accounts receivable, net of allowance for credit losses of 21,528 as of september 30, 2025, and 20,458 as of december 31, 2024
      		  71,187,000                                     
        intangible assets
      		  135,255,000 131,060,000 133,009,000 134,978,000 137,115,000 138,973,000 140,989,000 143,053,000 144,489,000 146,473,000 148,699,000 150,643,000 87,853,000 89,695,000 35,037,000 35,914,000                      
        trade accounts receivable, net of allowance for credit losses of 21,416 as of june 30, 2025, and 20,458 as of december 31, 2024
      		   77,190,000                                    
        trade accounts receivable, net of allowance for credit losses of 20,935 as of march 31, 2025, and 20,458 as of december 31, 2024
      		    71,478,000                                   
        trade accounts receivable, net of allowance for credit losses of 20,458 and 25,226
      		     69,021,000                                  
        redeemable preferred stock investment
      		       20,438,000 20,438,000 20,438,000 15,158,000 12,842,000 12,982,000 12,385,000 11,233,000 11,981,000 17,609,000 21,965,000 20,000,000                     
        notes payable, current portion
      		     412,000 412,000 412,000 413,000 1,183,000 2,890,000 4,560,000 5,608,000 5,639,000 5,481,000 5,793,000 6,086,000                       
        other current liabilities
      		         164,000 281,000 362,000 3,810,000 5,301,000 13,621,000 661,000 1,089,000 680,000 39,919,000 13,063,000 12,559,000                  1,253,000 
        trade accounts receivable, net of allowance for credit losses of 25,316 as of september 30, 2024, and 25,226 as of december 31, 2023
      		      57,315,000                                 
        trade accounts receivable, net of allowance for credit losses of 25,307 as of june 30, 2024, and 25,226 as of december 31, 2023
      		       56,573,000                                
        trade accounts receivable, net of allowance for credit losses of 25,831 and 25,226
      		        52,060,000                               
        trade accounts receivable, net of allowance for credit losses of 25,226 and 41,205
      		         51,132,000                              
        investment margin loan
      		            14,999,000 14,999,000 14,999,000 14,999,000 14,999,000 15,137,000 15,107,000 15,077,000 15,048,000 15,019,000                  
        total fulgent stockholders' equity
      		         1,136,101,000    1,266,685,000 1,277,047,000 1,304,765,000 1,306,132,000 1,158,749,000 1,036,780,000 912,729,000                    
        trade accounts receivable, net of allowance for credit losses of 29,091 and 41,205
      		          49,277,000                             
        deferred tax liability
      		          9,833,000                        243,000 243,000 243,000 243,000 503,000 
        accumulated other comprehensive loss
      		          -16,891,000 -20,746,000 -17,196,000 -20,903,000 -25,602,000 -22,417,000 -12,493,000              -57,000     -68,000 -85,000 -103,000  
        trade accounts receivable, net of allowance for credit losses of 33,173 and 41,205
      		           34,809,000                            
        trade accounts receivable, net of allowance for credit losses of 38,302 and 41,205
      		            43,549,000                           
        trade accounts receivable, net of allowance for credit losses of 41,205 and 11,217
      		             52,749,000                          
        income tax payable
      		              426,000 2,804,000 52,163,000 787,000 17,875,000 26,399,000 120,522,000 53,319,000 14,627,000  56,000 24,000 60,000          230,000 124,000  
        contingent consideration
      		                 10,000,000                      
        trade accounts receivable, net of allowance for credit losses of 35,410 and 11,217
      		              104,159,000                         
        trade accounts receivable, net of allowance for credit losses of 30,335 and 11,217
      		               133,303,000                        
        trade accounts receivable, net of allowance for credit losses of 22,126 and 11,217
      		                160,261,000                       
        trade accounts receivable, net of allowance for credit losses of 11,217 and 1,898 as of december 31, 2021 and 2020, respectively
      		                 138,912,000                      
        notes payable
      		                 6,147,000 5,947,000 5,899,000                    
        trade accounts receivable, net of allowance for credit losses of 6,893 and 1,898 as of september 30, 2021 and december 31, 2020, respectively
      		                  120,822,000                     
        acquisition-related intangible assets
      		                  36,684,000 6,829,000                    
        trade accounts receivable, net of allowance for credit losses of 6,044 and 1,898 as of june 30, 2021 and december 31, 2020, respectively
      		                   148,576,000                    
        trade accounts receivable, net of allowance for credit losses of 3,850 and 1,898 as of march 31, 2021 and december 31, 2020, respectively
      		                    216,509,000                   
        trade accounts receivable, net of allowance for doubtful accounts of 1,898 and 751, as of december 31, 2020 and 2019, respectively
      		                     183,857,000                  
        equity method investments
      		                      1,621,000 430,000 623,000 872,000 909,000 1,084,000 1,233,000 1,512,000 1,746,000 1,956,000 1,692,000 1,937,000 2,184,000     
        operating lease right-of-use asset
      		                     828,000 2,680,000 2,806,000 2,525,000 2,633,000 2,739,000 2,756,000 2,858,000           
        operating lease liabilities, short-term
      		                     267,000 512,000 501,000 431,000 420,000 409,000 401,000 393,000           
        operating lease liabilities, long-term
      		                     568,000 2,231,000 2,363,000 2,143,000 2,256,000 2,366,000 2,385,000 2,488,000           
        trade accounts receivable, net of allowance for doubtful accounts of 1,169 and 751, as of september 30, 2020 and december 31, 2019, respectively
      		                      90,680,000                 
        accumulated deficit
      		                      -15,426,000 -62,064,000 -65,385,000 -63,429,000 -63,133,000 -64,595,000 -64,926,000 -63,018,000 -60,965,000 -60,370,000 -59,321,000 -57,664,000 -56,040,000 -54,947,000 -54,922,000 -55,154,000 -55,967,000 
        trade accounts receivable, net of allowance for doubtful accounts of 864 and 751, as of june 30, 2020 and december 31, 2019, respectively
      		                       13,863,000                
        trade accounts receivable, net of allowance for doubtful accounts of 862 and 751, as of march 31, 2020 and december 31, 2019, respectively
      		                        6,371,000               
        trade accounts receivable, net of allowance for doubtful accounts of 751 and 590, as of december 31, 2019 and 2018, respectively
      		                         6,555,000              
        trade accounts receivable, net of allowance for doubtful accounts of 611 and 590, as of september 30, 2019 and december 31, 2018, respectively
      		                          5,292,000             
        trade accounts receivable, net of allowance for doubtful accounts of 585 and 590, as of june 30, 2019 and december 31, 2018, respectively
      		                           5,543,000            
        trade accounts receivable, net of allowance for doubtful accounts of 588 and 590, as of march 31, 2019 and december 31, 2018, respectively
      		                            4,563,000           
        trade accounts receivable, net of allowance for doubtful accounts of 590 and 287, as of december 31, 2018 and 2017, respectively
      		                             5,948,000          
        marketable securities, long term
      		                             6,386,000 4,250,000 7,460,000 10,285,000 14,883,000 17,860,000 17,243,000 19,643,000 25,597,000  
        deferred tax asset
      		                              929,000 592,000 505,000 126,000 27,000 37,000 44,000 54,000 86,000 
        accumulated other comprehensive income loss
      		                             -35,000          
        trade accounts receivable, net of allowance for doubtful accounts of 516 and 287, as of september 30, 2018 and december 31, 2017, respectively
      		                              6,077,000         
        trade accounts receivable, net of allowance for doubtful accounts of 516 and 287, as of june 30, 2018 and december 31, 2017, respectively
      		                               5,055,000        
        trade accounts receivable, net of allowance for doubtful accounts of 335 and 287, as of march 31, 2018 and december 31, 2017, respectively
      		                                4,969,000       
        trade accounts receivable, net of allowance for doubtful accounts of 287 and 151, as of december 31, 2017 and 2016, respectively
      		                                 4,005,000      
        trade accounts receivable, net of allowance for doubtful accounts of 138 and 151, respectively
      		                                  3,594,000     
        trade accounts receivable, net of allowance for doubtful accounts of 133 and 151, respectively
      		                                   4,186,000    
        accumulated losses of unconsolidated companies in excess of investment
      		                                   105,000    
        trade accounts receivable, net of allowance for doubtful accounts of 151 and 151, respectively
      		                                    4,601,000   
        total long-term assets
      		                                    25,650,000   
        trade accounts receivable, net of allowance for doubtful accounts of 151 and 75, as of december 31, 2016 and 2015, respectively
      		                                     4,364,000  
        current assets of discontinued operations
      		                                       
        non-current assets of discontinued operations
      		                                       
        liabilities and stockholders’/ members’ equity
      		                                       
        current liabilities of discontinued operations
      		                                       
        stockholders’/ members’ equity
      		                                       
        units 56,000 class d and 51,000 class p preferred units authorized, issued and outstanding, 44,000 class d and 49,000 class p common units authorized and 34,000 class d and 45,000 class p common units issued and outstanding, at december 31, 2015
      		                                       
        total stockholders’/ members’ equity
      		                                     54,479,000  
        total liabilities and stockholders’/ members’ equity
      		                                     58,040,000 22,758,000 
        cash
      		                                      8,205,000 
        trade accounts receivable, net of allowance for doubtful accounts of 48 and 75, respectively
      		                                      4,406,000 
        members' equity 56,000 class d and 51,000 class p preferred units authorized, issued and outstanding, 44,000 class d and 49,000 class p common units authorized and 34,000 class d and 45,000 class p common units issued and outstanding, at december 31, 2015
      		                                       
        total stockholders’/ members’equity
      		                                      17,245,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
                                              
          cash flow from operating activities:
        		                                      
          net loss from consolidated operations
        		-25,274,000 -23,650,000 -6,826,000 -19,256,000 -11,899,000  -14,694,000 -9,090,000 -13,846,000                              
          adjustments to reconcile net loss to net cash from operating activities:
        		                                      
          equity-based compensation
        		9,890,000 9,276,000 9,717,000 10,039,000 10,550,000 10,408,000 10,920,000 11,635,000 11,518,000 11,432,000 10,902,000 10,323,000 10,265,000 10,022,000 8,972,000 8,030,000 5,616,000 5,020,000 4,374,000 3,526,000 2,962,000 3,003,000 3,150,000 1,080,000 924,000 938,000 951,000 737,000 583,000 598,000 588,000 573,000 545,000 581,000 549,000 424,000 565,000 535,000 
          depreciation and amortization
        		6,000,000 6,112,000 6,038,000 6,054,000 5,919,000 6,192,000 5,920,000 6,153,000 6,663,000 6,533,000 6,419,000 6,312,000 6,879,000 9,802,000 9,820,000 8,345,000 4,695,000 3,491,000 3,173,000              516,000 473,000 438,000 405,000 412,000 420,000 
          adjustment for credit losses
        		1,189,000  1,128,000 2,591,000 2,075,000  947,000                                
          noncash lease expense
        		352,000 567,000 485,000 362,000 350,000 477,000 604,000 1,169,000 1,510,000 1,517,000 1,627,000 1,707,000 1,561,000 1,602,000 1,601,000 1,233,000 477,000 472,000 384,000 216,000 82,000 64,000 125,000 112,000 108,000 107,000 105,000 101,000 100,000          
          gain on disposal of fixed asset
        		-9,000                                      
          amortization of premium of marketable securities
        		-890,000             537,000 1,007,000 1,313,000 1,910,000 2,106,000 2,319,000 1,868,000 1,303,000 530,000 109,000 113,000 105,000 54,000 8,000 7,000 37,000 58,000 79,000 78,000 82,000 84,000 90,000 101,000 95,000  
          deferred taxes
        		-1,120,000 -104,000 -864,000 -113,000 -133,000 -364,000 -2,358,000 -457,000 -557,000 502,000 19,382,000 -3,218,000 -5,200,000 -3,346,000 2,705,000 -2,142,000 -5,497,000 -1,614,000 -3,519,000 -2,269,000 -786,000 -692,000    0     -352,000 -101,000 -434,000      
          unrecognized tax benefits
        		199,000 499,000 163,000 137,000 137,000 -1,762,000 31,000   -3,577,000    8,010,000 96,000 520,000 485,000 191,000 29,000 32,000 96,000 -12,000                 
          other
        		1,000 -4,000 1,000 12,000 21,000 -21,000 19,000 7,000 -12,000 8,000 -49,000   12,000 -6,000 -32,000 15,000 7,000 -14,000 0 -8,000 15,000 -1,000 36,000 -42,000 11,000 3,000 66,000 -28,000 26,000 -20,000 10,000 28,000      
          changes in operating assets and liabilities:
        		                                      
          trade accounts receivable
        		16,431,000 -15,377,000 4,907,000 -8,257,000 -4,524,000 -13,325,000 -1,585,000 -2,877,000 1,484,000 -5,208,000 -12,062,000 10,327,000 9,331,000 44,424,000 22,412,000 34,726,000 -32,924,000  32,543,000 67,055,000 -34,595,000                  
          income tax
        		-1,394,000 -71,881,000 -24,000 -34,793,000 1,761,000                                  
          other current and long-term assets
        		2,791,000 1,823,000 -1,371,000 -458,000 804,000 775,000 -4,673,000 -1,033,000 5,130,000 2,304,000 888,000 -2,135,000 -1,629,000 -8,059,000 5,576,000 -4,816,000 2,962,000 9,890,000 3,939,000 3,084,000 -9,109,000 -1,973,000 -15,349,000 -2,903,000 -924,000 -76,000 267,000 119,000 64,000          
          accounts payable
        		-408,000 924,000 -102,000 386,000 -658,000 -808,000 2,278,000 1,841,000 -245,000 129,000 -2,578,000 -2,592,000 -1,855,000 6,992,000 -22,073,000 -12,368,000 2,110,000 -3,204,000 1,254,000 -4,000,000 -6,256,000 7,942,000 12,391,000 377,000 1,907,000 -238,000 33,000 -203,000 79,000 277,000 1,169,000 -1,562,000 218,000 -377,000 569,000 -122,000 -433,000  
          contract liabilities
        		-627,000 1,325,000 -363,000 -144,000 582,000 -732,000 223,000            965,000 -7,046,000 -12,616,000                  
          customer deposits
        		2,470,000 -403,000 939,000 -99,000 83,000 681,000 632,000                                
          accrued liabilities and other liabilities
        		-2,123,000 12,325,000 -1,132,000 5,203,000 -7,485,000 628,000 -1,827,000 -2,813,000 51,000 14,531,000 4,195,000 4,596,000 -9,114,000 -18,394,000 -13,169,000 8,495,000 -8,231,000 14,034,000 -4,037,000   10,486,000 21,499,000                
          operating lease liabilities
        		-381,000 -446,000 -470,000 -355,000 -354,000 -483,000 -601,000    -1,618,000         -211,000 -82,000 -64,000 -120,000 -104,000 -101,000 -99,000 -122,000 -95,000 -93,000          
          net cash from operating activities
        		7,097,000 -78,143,000 11,107,000 -30,171,000 -4,431,000 25,018,000 -15,509,000 4,285,000 7,266,000 14,933,000 10,240,000 9,737,000 -7,907,000 33,207,000 20,776,000 11,126,000 188,411,000 77,086,000 152,201,000 76,111,000 233,179,000  9,415,000 -4,409,000 1,366,000         -1,241,000 500,000 1,365,000 707,000 1,254,000 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0         0 0 0 0 0 
          free cash flows
        		7,097,000 -78,143,000 11,107,000 -30,171,000 -4,431,000 25,018,000 -15,509,000 4,285,000 7,266,000 14,933,000 10,240,000 9,737,000 -7,907,000 33,207,000 20,776,000 11,126,000 188,411,000 77,086,000 152,201,000 76,111,000 233,179,000  9,415,000 -4,409,000 1,366,000         -1,241,000 500,000 1,365,000 707,000 1,254,000 
          cash flow from investing activities:
        		                                      
          maturities of marketable securities
        		81,711,000 78,097,000 40,235,000 60,230,000 32,445,000 71,787,000 117,935,000 64,623,000 95,450,000 131,668,000 118,043,000 117,439,000 141,408,000 100,821,000 61,281,000 42,672,000 27,760,000 22,326,000 26,978,000 20,080,000 14,458,000 6,800,000 5,792,000 2,401,000 4,926,000 4,750,000 8,100,000 7,900,000 3,600,000 8,609,000 7,704,000 5,806,000 5,850,000 5,785,000 1,800,000 2,600,000 1,000,000  
          proceeds from sale of fixed assets
        		8,000 0 3,000 0 2,000 0 38,000 17,000 258,000 335,000 22,000 220,000 198,000 172,000 222,000 4,000 14,000 41,000 9,000 0 13,000                  
          purchase of marketable securities
        		-10,011,000 -61,963,000    -98,206,000 -115,380,000 -63,088,000 -195,741,000 -148,313,000 -93,064,000 -106,611,000 -143,926,000 -160,715,000 -11,779,000 -115,355,000 -130,133,000 -186,551,000 -99,132,000 -205,337,000 -219,470,000 -310,796,000 -1,176,000 -4,395,000 -7,992,000 -40,231,000 -1,668,000 -4,190,000 -5,988,000 -11,022,000 -1,695,000 -6,787,000 -4,683,000 -6,407,000 -1,670,000 -802,000 -2,780,000  
          purchases of fixed assets
        		-5,202,000 -4,980,000 -6,050,000 -6,826,000 -4,718,000 -3,778,000 -19,537,000 -12,944,000 -4,056,000 -3,106,000 -4,923,000 -12,144,000 -2,034,000 -4,722,000 -5,435,000 -3,258,000 -5,360,000 -5,983,000 -3,402,000 -2,935,000 -11,492,000 -23,794,000 -10,129,000 -411,000 -796,000 -461,000 -88,000 -499,000 -134,000 -123,000 -1,047,000 -36,000 -1,116,000 -1,141,000 -237,000 -1,427,000 -90,000 -409,000 
          acquisition of businesses, net of cash
        		-55,567,000                                      
          net cash from investing activities
        		10,939,000 11,154,000 19,084,000 53,404,000 27,729,000 -27,455,000 8,985,000 7,304,000 -47,186,000 24,270,000 20,078,000 -1,096,000 -4,354,000 -92,599,000 44,289,000 -213,692,000 688,000 -140,259,000 -34,793,000 -155,005,000 -216,491,000 -318,767,000 -1,404,000 -2,405,000 -3,862,000 -36,079,000 6,344,000 3,211,000 -2,522,000 -2,536,000 4,962,000 -1,527,000 51,000 -1,763,000 -2,568,000 4,152,000 -1,870,000 -39,416,000 
          cash flow from financing activities:
        		                                      
          repurchase of common stock
        		-40,078,000 0 0 -2,205,000 -8,679,000 0 0 0 -225,000 -22,862,000    -29,058,000 -34,702,000                        
          common stock withholding for employee tax obligations
        		-4,200,000 -447,000 -357,000 -345,000 -1,887,000 -242,000 -431,000 -544,000 -1,682,000 -1,114,000 -517,000 -232,000 -869,000 -316,000 -522,000 -436,000 -494,000 -688,000 -2,915,000                    
          repayment of notes payable
        		-476,000 0 0 -1,000 -470,000 0 -1,000 -464,000 -765,000 -1,837,000 -1,630,000   0 1,000 7,000 -375,000                      
          principal paid for finance lease
        		-88,000 -88,000 -88,000 -87,000 -136,000 -136,000 -135,000 -138,000 -135,000  -129,000 -231,000 -232,000  -239,000 -149,000 -81,000 -4,000                     
          proceeds from exercise of stock options
        		9,000         0 0   12,000 0 3,000 16,000 1,000 17,000 24,000 44,000 2,000 62,000 28,000 12,000 12,000 17,000 5,000 4,000 5,000 1,000 7,000 2,000 4,000 4,000    
          net cash from financing activities
        		-44,833,000 -534,000 -445,000 -2,638,000 -11,172,000 -327,000 -567,000 -1,146,000 -2,807,000 -25,951,000 -4,474,000 -16,259,000 -1,101,000 -29,593,000 -35,462,000 -11,152,000 -934,000 13,154,000 -2,989,000 27,893,000 47,347,000 218,903,000 42,571,000 -59,000 -164,000 27,639,000 1,127,000 5,000 4,000 5,000 1,000 7,000 2,000 4,000 4,000   37,854,000 
          effect of exchange rate changes on cash and cash equivalents
        		3,000 75,000 15,000 4,000 11,000 -134,000 157,000 -9,000 -69,000 145,000 -116,000 -206,000 28,000 -279,000 387,000 -571,000 10,000 36,000 -3,000   3,000 18,000 2,000 -3,000 -1,000 -17,000 -14,000 15,000 0 -23,000 -43,000 22,000 12,000     
          net increase in cash, cash equivalents, and restricted cash
        		-26,794,000 -67,448,000 29,761,000 20,599,000 12,137,000 -2,898,000                                 
          cash, cash equivalents, and restricted cash at beginning of period
        		50,328,000 0 0 0 55,279,000 0                                 
          cash, cash equivalents, and restricted cash at end of period
        		23,534,000 -67,448,000 29,761,000 20,599,000 67,416,000 -2,898,000                                 
          supplemental disclosures of cash flow information:
        		                                      
          income taxes paid, net of refunds received
        		-551,000                                      
          interest paid
        		44,000 4,000 4,000 -17,000 61,000 50,000 10,000    21,000                            
          supplemental disclosures of non-cash investing and financing activities:
        		                                      
          purchases of fixed assets in accounts payable
        		2,606,000 -377,000 -510,000 259,000 2,322,000 -682,000 -2,295,000 44,000 4,739,000 511,000 -2,437,000 1,188,000 2,537,000 1,299,000 -468,000 104,000 2,054,000 -1,204,000 1,537,000 -59,000 801,000 580,000 2,325,000   -323,000             
          acquisition of business in accrued liabilities
        		141,000                                      
          operating lease right-of-use assets obtained in exchange for lease liabilities
        		210,000 541,000 0   0 12,000   0 0   0    91,000 941,000 397,000 368,000 9,000 0   0             
          cash flow from operating activities
        		                                      
          goodwill impairment loss
        		                                      
          provision (adjustment) for credit losses
        		                                      
          loss on disposal of fixed asset
        		 0 -1,000 0 -2,000 103,000 45,000 -11,000 183,000 -124,000 418,000   202,000 -9,000 59,000 250,000 71,000 181,000 375,000 223,000 320,000    0 0   0 33,000 4,000 51,000 0 0    
          discount premium of marketable securities
        		                                      
          net realized loss on marketable securities
        		 -41,000    52,000 71,000 291,000 580,000                              
          impairment loss
        		 0 0                                    
          cash flow from investing activities
        		                                      
          proceeds from sale of marketable securities
        		     2,742,000 25,929,000 18,696,000 56,903,000     6,769,000 0 0 133,407,000 29,940,000 104,113,000   9,023,000                 
          acquisition of businesses, net of cash acquired
        		             -34,924,000 0   0 -43,359,000                    
          cash flow from financing activities
        		                                      
          repayment of investment margin loan
        		          0                            
          supplemental disclosures of cash flow information
        		                                      
          income taxes paid
        		 63,509,000 133,000 32,749,000 54,000 946,000 24,739,000 596,000 1,307,000 563,000 62,000 956,000 1,680,000 12,000 1,199,000 54,547,000 435,000 67,529,000 49,560,000 119,947,000 33,000 20,584,000 0   0 0   0 0   0 1,000    
          supplemental disclosures of non-cash investing and financing activities
        		                                      
          contingent consideration for business acquisition included in additional paid-in capital
        		 0                                     
          holdback for acquisition of business included in other long-term liabilities
        		 0                                     
          operating lease right-of-use assets reduced due to lease modification and termination
        		 -1,000 0   0 0                                
          operating lease liabilities removed due to purchasing underlying assets
        		     0                                 
          finance lease right-of-use assets reduced due to lease modification and termination
        		          0                            
          amortization of discount of marketable securities
        		  -1,097,000 -1,406,000 -1,658,000  -1,335,000 -1,486,000 -1,184,000                              
          cash and cash equivalents
        		  29,761,000 20,599,000 67,281,000 -2,898,000                                 
          restricted cash
        		  0 0 135,000 0                                 
          total cash, cash equivalents, and restricted cash
        		  29,761,000 20,599,000 67,416,000 -2,898,000                                 
          sale of fixed assets in other receivable
        		        11,000                              
          net income from consolidated operations
        		         -134,334,000 -13,466,000 -11,590,000 -15,849,000 -24,076,000 1,343,000 11,099,000 153,557,000 103,677,000 122,224,000                    
          adjustments to reconcile net income to net cash from operating activities:
        		                                      
          (adjustment) provision for credit losses
        		                                      
          amortization of (discount) premium of marketable securities
        		          -1,190,000 -714,000 -478,000                          
          impairment of available-for-sale debt securities
        		     0                                 
          purchase of preferred stock of privately held company
        		             0                         
          contingent consideration payout related to a business acquisition
        		             0 0 0 -10,000,000                      
          stock consideration in a business combination
        		                                      
          maturities of marketable securities in ither current assets
        		                                      
          purchases of fixed assets in notes payable
        		             0 0 0 3,833,000                      
          finance lease right-of-use assets obtained in exchange for lease liabilities
        		             0                         
          prepaid income tax
        		                                      
          net decrease in cash and cash equivalents
        		       10,434,000 -42,796,000                -2,663,000              
          cash and cash equivalents at beginning of period
        		       0 97,473,000 0 0 0 79,506,000 0 0 0 164,894,000 0 0 0 87,426,000 0 0 0 11,965,000              
          cash and cash equivalents at end of period
        		       10,434,000 54,677,000 13,397,000 25,728,000 -7,824,000 66,172,000 -89,264,000 29,990,000 -214,289,000 353,069,000 -49,983,000 114,416,000 -51,000,000 151,461,000 34,395,000 50,600,000 -6,871,000 9,302,000              
          gain for credit losses
        		        -2,497,000                              
          operating and finance lease liabilities
        		        -1,512,000    -1,526,000 -1,500,000 -1,652,000 -1,202,000 -477,000 -474,000                     
          cash paid for interest
        		        439,000                              
          purchases of marketable securities in other current liabilities
        		            3,519,000                          
          operating lease right-of-use assets reduced due to lease termination
        		        57,000                              
          provision (gain) for credit losses
        		                                      
          amortization (discount) of premium of marketable securities
        		                                      
          net loss on marketable securities
        		                513,000 591,000                     
          gain in equity-method investments
        		                                      
          income tax payable
        		             -427,000 -2,378,000 -49,398,000 51,376,000 -17,088,000 -8,524,000 -94,123,000 67,203,000 38,692,000 14,627,000 -58,000 34,000 -36,000             
          purchases of intangible assets
        		                                      
          purchase of redeemable preferred stock
        		                 0                     
          proceeds from public offerings of common stock, net of issuance costs
        		                 13,849,000    203,898,000    27,648,000             
          proceeds from noncontrolling interest
        		                 0 0                    
          principal paid for finance leases
        		                                      
          re-payment for the margin account
        		                                      
          net increase in cash and cash equivalents
        		         13,397,000   -13,334,000 -89,264,000 29,990,000 -214,289,000 188,175,000 -49,983,000 114,416,000 -51,000,000 64,035,000 34,395,000 50,600,000                
          maturities of marketable securities in other current assets
        		                                      
          operating lease right-of-use assets reduced due to lease modification or termination
        		                                      
          finance lease right-of-use assets reduced due to lease modification or termination
        		                                      
          contingent consideration for business acquisition included in current liabilities
        		                                      
          public offerings costs included in accounts payable
        		                   -20,000 50,000 -15,000 372,000 1,000 1,000 -2,000             
          provision for credit losses
        		          -2,347,000      11,574,000 4,824,000 848,000 2,195,000 1,064,000                  
          investment in private equity securities
        		               0 -15,000,000                      
          purchase of marketable securities in other current liabilities
        		                        500,000              
          benefit from credit losses
        		            -113,000 7,340,000 6,522,000                        
          (gain) loss on disposal of fixed asset
        		            -179,000                          
          net income on marketable securities
        		             66,000 9,000                        
          equity loss in investee
        		                     -143,000 189,000 193,000 249,000 174,000 175,000 149,000 279,000 234,000 210,000 246,000 245,000 247,000     
          (gain) loss in equity-method investments
        		                                      
          investment in equity-method investees
        		                                      
          borrowing under margin account
        		                   29,000 29,000                  
          public offerings proceeds in other receivable included in other current assets
        		                                      
          allowance for credit losses at beginning of year
        		                                      
          impact of asu 2016-13 adoption
        		                                      
          current period provision
        		                                      
          write-downs
        		                                      
          allowance for credit losses at end of year
        		                                      
          gain on equity method investment
        		                                      
          contingent consideration for business acquisition included in other current liabilities
        		                                      
          loss in equity-method investments
        		                                      
          accounts receivable
        		                     -93,923,000 -77,120,000 -7,541,000 104,000 -1,427,000 220,000 -1,046,000 1,414,000 23,000 -1,003,000 -277,000 -713,000 -545,000 581,000 415,000 -237,000  
          gain on equity-method investments
        		                                      
          customer deposit
        		                  -3,817,000 27,903,000 16,816,000                  
          public offerings proceeds included in other current assets
        		                                      
          adjustments to reconcile net income to net cash provided (used in) by operating activities:
        		                                      
          holding loss on equity securities
        		                   15,000 345,000                  
          proceeds from (payment for) public offerings of common stock, net of issuance costs
        		                   27,869,000 47,787,000                  
          operating lease right-of-use assets reduced due to lease modification
        		                   0 185,000                  
          net income
        		                    200,691,000 166,307,000 46,638,000         -1,049,000 -1,910,000 -1,624,000 -1,093,000 -25,000 232,000  
          adjustments to reconcile net income to net cash provided by operating activities:
        		                                      
          depreciation
        		                    1,922,000 1,122,000 722,000 549,000 569,000 558,000 503,000 511,000 535,000 538,000 547,000        
          other current liabilities
        		                    3,924,000                  
          repurchases of capital stock
        		                    -513,000 -16,000 0 0 -46,000              
          provision for bad debt
        		                     729,000 306,000 14,000 121,000     79,000 0 182,000 48,000 149,000    103,000 
          impairment loss in equity method investments
        		                                      
          net cash from operations
        		                         -116,000 3,903,000 675,000 1,055,000  -105,000 -57,000 -1,291,000      
          purchase of equipment contributed to equity-method investee
        		                                      
          investment in equity method investee
        		                     0                 
          operating lease liabilities removed due to purchasing of underlying assets
        		                                      
          impairment loss in equity method investment
        		                                      
          proceeds from disposal of fixed assets
        		                                      
          purchase of equipment contributed to equity method investee
        		                             0 0   0     
          adjustments to reconcile net income to net cash (used in) provided by operating activities:
        		                                      
          payment of public offering costs
        		                       -87,000 -130,000              
          net loss
        		                        -1,956,000  1,462,000 331,000 -1,908,000 -2,053,000         
          accrued liabilities and other current liabilities
        		                        268,000              
          fixed assets included in accounts payable
        		                        43,000   -40,000 45,000 12,000 -938,000 1,005,000 6,000 115,000 -44,000 932,000 11,000 1,076,000 
          benefit from bad debt
        		                                      
          accrued liabilities
        		                          222,000 -13,000 -7,000 199,000 -954,000 1,130,000 158,000 115,000 -95,000 768,000 310,000  
          net increase in cash
        		                                 -2,988,000 -1,995,000 4,739,000 -1,163,000 -308,000 
          cash balance at beginning of period
        		                          0 0 6,736,000 0 0 0 6,490,000 0 0 0 7,897,000 0 
          cash balance at end of period
        		                          11,357,000 3,877,000 5,288,000 -1,753,000 4,835,000 -1,620,000 5,274,000 -2,988,000 -1,995,000 4,739,000 6,734,000 -308,000 
          net decrease in cash
        		                           3,877,000 -1,448,000  4,835,000 -1,620,000 -1,216,000      
          deferred income taxes
        		                                     -171,000 
          other current assets
        		                             -124,000 193,000 147,000 -125,000 9,000 -721,000 -482,000 -343,000  
          taxes payable
        		                                 0 -1,000 -288,000 165,000  
          cash from operating activities
        		                                      
          sale of marketable securities
        		                                 0 0    
          payment of initial public offering costs
        		                                 0 0    
          income from discontinued operations
        		                                     0 
          loss from continuing operations
        		                                      
          fair value adjustment recorded upon issuance of class d-2 preferred units
        		                                      
          cash from continuing operations
        		                                 -1,241,000 500,000 1,365,000 707,000 1,254,000 
          cash from discontinued operations
        		                                     0 
          proceeds from issuance of common stock, net of offering costs
        		                                      
          cash distributed in split-off of pharma business
        		                                     0 
          distribution to class d-1 preferred unitholder
        		                                      
          proceeds from issuance of class d-2 preferred units
        		                                      
          repurchase and retirement of class d-1 preferred and class d common units
        		                                     -1,000 
          tax distribution to class d common and preferred unitholders
        		                                      
          initial public offering costs included in accounts payable and accrued expenses
        		                                      
          income from continuing operations
        		                                  -1,093,000 -25,000 232,000  
          return of capital contribution
        		                                      
          issuance costs of class d-2 preferred units
        		                                      
          tax distribution to class d common and preferred unitholders in other current liabilities
        		                                      
          deferred initial public offering costs included in accounts payable
        		                                      
          equity in net loss of affiliate
        		                                      
          excess tax benefits
        		                                    -59,000  
          capital contributions
        		                                      
          supplemental cash flow information:
        		                                      
          operating expenses:
        		                                      
          research and development
        		                                      
          general and administrative
        		                                      
          total operating expenses
        		                                      
          operating income
        		                                      
          other income
        		                                      
          income
        		                                      
          weighted-average class p common units - profits interests - outstanding, basic and diluted
        		                                      
          weighted-average class p preferred units outstanding, basic and diluted
        		                                      
          gain on disposal of fixed assets
        		                                      
          amortization of premium on marketable securities
        		                                      
          fair value adjustment recorded upon issuance of d-2 preferred units
        		                                     0 
          income taxes payable
        		                                      
          issuance of class d-2 preferred units, net of issuance costs
        		                                      
          recapitalization
        		                                      
          increase in accounts receivable
        		                                      
          increase in other current assets
        		                                      
          increase in accounts payable
        		                                      
          increase in accrued liabilities
        		                                      
          proceeds from issuance of d-2 units